A potent proresolving mediator 17R-resolvin D2 from human macrophages, monocytes, and saliva
Science Advances · 2024
DOI: 10.1126/sciadv.adq4785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Mélissa Simard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospi…. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Macrophages, Saliva, Monocytes. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Production of specialized proresolving mediators (SPMs) during the resolution phase in the acute inflammatory response is key to orchestrating complete resolution. Here, we uncovered a trihydroxy resolvin in fresh human saliva. We identified and determined its complete stereochemistry as 7S,16R,17R-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic acid (17R-RvD2) using total organic synthesis and matching of physical properties. The 17R-RvD2 was produced by activated human M2-like macrophages, M1-like macrophages, and human peripheral blood monocytes. 17R-RvD2 displayed potent proresolving functions (picomolar to nanomolar). Topical application of 17R-RvD2 on mouse ear skin reduced neutrophilic infiltration (~50%). 17R-RvD2 increased M2 markers CD206 and CD163 on human monocyte–derived macrophages and enhanced efferocytosis of senescent red blood cells by M2-like macrophages (EC 50 ~ 2.6 × 10 −14 M). In addition, 17R-RvD2 activated the RvD2 receptor and was equipotent to its epimer RvD2. 17R-RvD2 also significantly increased phagocytosis of Escherichia coli by human neutrophils. Together, these results establish the complete stereochemistry and potent proresolving functions of the previously unknown 17R-RvD2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
- Department of Cell Biology and Neuroscience, Virtua Health College of Medicine & Life Sciences of Rowan University, Stratford, NJ 08084, USA.
ORCID-Profile: Mélissa Simard, Robert Nshimiyimana, Nan Chiang, Ana R Rodriguez, Bernd W Spur, Charles N Serhan
Förderung
- NIGMS NIH HHS
Zitieren
APA
Simard, M., Nshimiyimana, R., Chiang, N., Rodriguez, A. R., Spur, B. W., & Serhan, C. N. (2024). A potent proresolving mediator 17R-resolvin D2 from human macrophages, monocytes, and saliva. Science Advances. https://doi.org/10.1126/sciadv.adq4785
Vancouver
Simard M, Nshimiyimana R, Chiang N, Rodriguez AR, Spur BW, Serhan CN. A potent proresolving mediator 17R-resolvin D2 from human macrophages, monocytes, and saliva. Science Advances. 2024. doi:10.1126/sciadv.adq4785
BibTeX
@article{Simard2024,
author = {Simard, Mélissa and Nshimiyimana, Robert and Chiang, Nan and Rodriguez, Ana R and Spur, Bernd W and Serhan, Charles N},
title = {A potent proresolving mediator 17R-resolvin D2 from human macrophages, monocytes, and saliva},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adq4785}
}
EUVIMED